Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)
| Market Closed - Nasdaq 09:16:01 14/01/26 am AEDT | 5-day change | 1st Jan Change | ||
| 23,709.87 PTS | -0.10% |
|
+0.69% | +2.01% |
| 22/11 | Vaneck BNB ETF shares expected to be approved for listing on Nasdaq | RE |
| 22/11 | Cheer Holding receives Nasdaq delisting notice subject to hearing request | RE |
Published on 01/10/2026 at 12:11 pm AEDT - Modified on 01/10/2026 at 12:16 pm AEDT
Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)

Highest NASDAQ Composite increases |
|
|---|---|
| +14,900.00% | |
| +9,900.00% | |
| +9,900.00% | |
| +9,900.00% | |
| +9,900.00% |
The sharpest declines in NASDAQ Composite. |
|
|---|---|
| -99.00% | |
| -99.00% | |
| -99.00% | |
| -99.00% | |
| -99.80% |
Select your edition
All financial news and data tailored to specific country editions